Coronavirus: Section three trials of India-made vaccine start | India
The study for India's first COVID-19 vaccine Covaxin has started with around 26,000 participants, Bharat Biotech announced.The third phase of trials of India's first vaccine against COVID-19 has begun in the largest human trials that have…